相似文献
1
Annexin-A1: The culprit or the solution?
Immunology. 2022 May;166(1):2-16. doi: 10.1111/imm.13455. Epub 2022 Mar 1.
2
Annexin A1: potential for glucocorticoid sparing in RA.
Nat Rev Rheumatol. 2013 Oct;9(10):595-603. doi: 10.1038/nrrheum.2013.126. Epub 2013 Aug 20.
3
Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn's Disease.
Front Immunol. 2021 Sep 17;12:714138. doi: 10.3389/fimmu.2021.714138. eCollection 2021.
4
Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling.
EMBO Mol Med. 2011 Feb;3(2):102-14. doi: 10.1002/emmm.201000113. Epub 2011 Jan 20.
5
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system.
Prostaglandins Other Lipid Mediat. 2012 Aug;98(3-4):94-100. doi: 10.1016/j.prostaglandins.2011.11.005. Epub 2011 Nov 23.
6
Annexin A1 in the brain--undiscovered roles?
Trends Pharmacol Sci. 2008 Mar;29(3):135-42. doi: 10.1016/j.tips.2007.12.003. Epub 2008 Feb 11.
7
Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
J Immunol. 2010 Mar 1;184(5):2611-2619. doi: 10.4049/jimmunol.0903526. Epub 2010 Jan 27.
8
The annexin 1 receptor(s): is the plot unravelling?
Trends Pharmacol Sci. 2003 Nov;24(11):574-9. doi: 10.1016/j.tips.2003.09.010.
9
Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Autoimmunity. 2017 Jun;50(4):257-268. doi: 10.1080/08916934.2017.1300884. Epub 2017 Mar 16.
10
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.
Pharmacol Ther. 2015 Apr;148:47-65. doi: 10.1016/j.pharmthera.2014.11.012. Epub 2014 Nov 25.
引用本文的文献
1
Single-cell transcriptomics uncovers key immune drivers of vaccine efficacy in cattle.
BMC Genomics. 2025 Aug 18;26(1):750. doi: 10.1186/s12864-025-11915-0.
2
PPARγ controls ESCRT-dependent fibroblast-like synoviocyte exosome biogenesis and alleviates chondrocyte osteoarthritis mediated by exosomal ANXA1.
J Orthop Translat. 2025 Jun 27;53:187-205. doi: 10.1016/j.jot.2025.06.008. eCollection 2025 Jul.
3
Roles of Annexin A1 Expression in Small Cell Lung Cancer.
Cancers (Basel). 2025 Apr 23;17(9):1407. doi: 10.3390/cancers17091407.
4
The -formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease.
Front Immunol. 2025 Mar 4;16:1568629. doi: 10.3389/fimmu.2025.1568629. eCollection 2025.
5
Genetically Defined Organoid Models Reveal Mechanisms Driving Squamous Cell Neoplastic Evolution and Identify Potential Therapeutic Vulnerabilities.
bioRxiv. 2025 Jan 22:2025.01.18.631624. doi: 10.1101/2025.01.18.631624.
6
The Protective Effects of Annexin A1 in Acute Lung Injury Mediated by Nrf2.
Immun Inflamm Dis. 2025 Jan;13(1):e70111. doi: 10.1002/iid3.70111.
7
Annexin A1: The dawn of ischemic stroke (Review).
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2024.13427. Epub 2025 Jan 3.
8
Annexin A1 Mitigates Blood-Brain Barrier Disruption in a Sepsis-Associated Encephalopathy Model by Enhancing the Expression of Occludin and Zonula Occludens-1 (ZO-1).
CNS Neurosci Ther. 2024 Dec;30(12):e70173. doi: 10.1111/cns.70173.
9
Placental small extracellular vesicles from normal pregnancy and gestational diabetes increase insulin gene transcription and content in β cells.
Clin Sci (Lond). 2024 Nov 20;138(22):1481-1502. doi: 10.1042/CS20241782.
10
The protective effects of annexin A1 against oxidized-LDL-induced monocytes adhesion to endothelial cells: implication in atherosclerosis.
J Thromb Thrombolysis. 2025 Feb;58(2):267-275. doi: 10.1007/s11239-024-03050-6. Epub 2024 Oct 13.
本文引用的文献
1
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction.
JACC Basic Transl Sci. 2021 Aug 23;6(8):676-689. doi: 10.1016/j.jacbts.2021.07.007. eCollection 2021 Aug.
2
Annexin A1 as a potential prognostic biomarker for COVID-19 disease: Case-control study.
Int J Clin Pract. 2021 Oct;75(10):e14606. doi: 10.1111/ijcp.14606. Epub 2021 Jul 14.
3
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1).
Oncoimmunology. 2021 May 14;10(1):1926074. doi: 10.1080/2162402X.2021.1926074.
4
Ability of serum annexin A1 to predict 6-month poor clinical outcome following aneurysmal subarachnoid hemorrhage.
Clin Chim Acta. 2021 Aug;519:142-147. doi: 10.1016/j.cca.2021.04.020. Epub 2021 Apr 28.
5
Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Autoimmunity. 2021 Mar;54(2):76-87. doi: 10.1080/08916934.2021.1887148. Epub 2021 Feb 18.
6
Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors.
Cells. 2020 Dec 18;9(12):2719. doi: 10.3390/cells9122719.
7
Inhibition of formyl peptide receptor 1 activity suppresses tumorigenicity and attenuates the invasion and migration of lung adenocarcinoma cells under hypoxic conditions .
Ann Transl Med. 2020 Sep;8(18):1174. doi: 10.21037/atm-20-5864.
8
Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.
Med Hypotheses. 2020 Dec;145:110352. doi: 10.1016/j.mehy.2020.110352. Epub 2020 Oct 21.
9
Blood M2a monocyte polarization and increased formyl peptide receptor 1 expression are associated with progression from latent tuberculosis infection to active pulmonary tuberculosis disease.
Int J Infect Dis. 2020 Dec;101:210-219. doi: 10.1016/j.ijid.2020.09.1056. Epub 2020 Sep 21.
10
Contribution of annexin A1 to anticancer immunosurveillance.
Oncoimmunology. 2019 Aug 14;8(11):e1647760. doi: 10.1080/2162402X.2019.1647760. eCollection 2019.
Zotero 插件
